Skip to content
Apex Nursing

Guide — Oncology

Cancer Fundamentals for Nurses

Cancer is a family of diseases characterized by uncontrolled cell proliferation and loss of normal regulatory mechanisms. This guide covers the biology of cancer, tumor classification, metastasis, staging, risk factors, warning signs, and the nurse's role in early detection and patient support.

12 min read · Oncology

Educational use only. This content is intended for nursing students and exam preparation. Oncology care requires individualized clinical decision-making and institutional protocols. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.

What Is Cancer?

Cancer occurs when normal cellular regulatory mechanisms fail — allowing cells to proliferate without the usual growth-inhibiting signals, resist apoptosis (programmed cell death), and invade surrounding tissues. The hallmarks of cancer include: sustained proliferative signaling, evasion of growth suppressors, resistance to apoptosis, replicative immortality, angiogenesis induction, and tissue invasion/metastasis.

Cancer development is a multi-step process: initiation (irreversible DNA mutation from carcinogens), promotion (repeated exposure that stimulates mutated cells to proliferate), and progression (further mutations enabling invasion and spread).

Benign vs. Malignant Tumors

FeatureBenignMalignant (Cancer)
Cell appearanceWell-differentiated, resemble normal tissuePoorly differentiated or undifferentiated (anaplastic)
Growth rateSlow, self-limitingRapid, uncontrolled
Growth patternEncapsulated, expansive — pushes aside tissueInvasive — infiltrates and destroys surrounding tissue
MetastasisDoes NOT metastasizeCAN metastasize to distant sites
Recurrence after removalRarely recursMay recur locally or distally
Effect on hostLocal compression — typically not life-threateningLife-threatening — destroys tissue, depletes nutrients, metastasizes
Naming conventionSuffix: -oma (lipoma, adenoma, fibroma)Carcinoma (epithelial), sarcoma (mesenchymal), lymphoma, leukemia

Metastasis Pathways

Lymphatic spread

Most common initial route — cancer cells enter lymph channels and spread to regional lymph nodes. Lymph node involvement is key in staging and prognosis. Example: breast cancer → axillary nodes.

Hematogenous spread

Cancer cells enter blood vessels and travel to distant organs. Most common sites: liver (colon, GI cancers), lung (most cancers), bone (breast, prostate, lung), brain (lung, breast, melanoma).

Direct extension

Tumor grows into adjacent structures by direct invasion. Example: rectal cancer invading the bladder; lung cancer invading the chest wall.

Transcoelomic spread

Cancer cells shed into body cavities (peritoneal, pleural) and implant on serosal surfaces. Example: ovarian cancer seeding the peritoneum.

Common metastatic sites: Liver, lung, bone, and brain are the most common destinations for hematogenous spread. Bone mets → pain, fracture, hypercalcemia. Brain mets → headache, focal deficits, seizures.

TNM Staging System

ComponentWhat It DescribesKey Values
T — TumorSize and local extent of the primary tumorTX (cannot assess), T0 (no primary tumor), Tis (carcinoma in situ), T1–T4 (increasing size/invasion)
N — NodesRegional lymph node involvementNX (cannot assess), N0 (no node involvement), N1–N3 (increasing node involvement)
M — MetastasisPresence of distant metastasisMX (cannot assess), M0 (no distant metastasis), M1 (distant metastasis present)

Stage I

Small, localized — best prognosis

Stage II

Larger, may involve nearby tissue or nodes

Stage III

Regional spread — more extensive lymph node involvement

Stage IV

Distant metastasis — poorest prognosis

Risk Factors

Modifiable Risk Factors

  • Tobacco use (lung, oral, bladder, pancreas, cervix)
  • Excessive alcohol consumption
  • Obesity and physical inactivity
  • Diet: high-fat, low-fiber, processed meats
  • UV radiation and sun exposure (skin cancers)
  • Occupational carcinogens (asbestos, benzene, chromium)
  • Certain viral infections: HPV, HBV, HCV, EBV, H. pylori
  • Chronic inflammation (IBD → colorectal; cirrhosis → hepatocellular)

Non-Modifiable Risk Factors

  • Age (most cancers increase in incidence with age)
  • Sex/gender (certain cancers are sex-linked: prostate, ovarian)
  • Genetic predisposition: BRCA1/2 (breast/ovarian), Lynch syndrome (colorectal), Li-Fraumeni
  • Family history of cancer
  • Personal history of prior malignancy
  • Race/ethnicity (prostate CA higher in Black men; gastric CA higher in Asian populations)
  • Immunosuppression (HIV, transplant — higher risk of Kaposi's, lymphoma)

CAUTION Warning Signs

LetterWarning SignAssociated Cancers
CChange in bowel or bladder habitsColorectal, bladder, prostate
AA sore that does not healSkin, oral, lip
UUnusual bleeding or dischargeUterine, cervical, bladder, colorectal
TThickening or lump in breast, testes, or elsewhereBreast, testicular, thyroid, lymphoma
IIndigestion or difficulty swallowingEsophageal, gastric, head and neck
OObvious change in wart or moleMelanoma and other skin cancers
NNagging cough or hoarsenessLung, laryngeal, thyroid

Constitutional symptoms (“B symptoms”): fever, drenching night sweats, and unintentional weight loss >10% body weight — particularly associated with lymphoma and other hematologic malignancies.

Nursing Considerations

Early detection advocacy

Educate patients about recommended screening schedules — mammography (40/50+), colonoscopy (45+), Pap smear (21+), low-dose CT for lung cancer (high-risk 50–80 year olds with smoking history), PSA discussion (50+ with shared decision-making).

Psychosocial support

A cancer diagnosis triggers grief, fear, anger, and depression in patients and families. Use therapeutic communication, acknowledge emotional responses without minimizing them, and refer to oncology social work, counseling, or support groups.

Symptom management

Cancer and its treatment cause overlapping symptoms — pain, fatigue, nausea, anorexia, dyspnea, and sleep disturbance. Anticipate and proactively manage symptoms rather than waiting for patient complaints.

Patient education

Patients need to understand their diagnosis, staging, treatment plan, expected side effects, and self-care strategies. Tailor education to health literacy level. Include family caregivers in education when appropriate.

Goals of care conversations

Help patients articulate their care goals. Curative intent vs. palliative vs. hospice is not always clear to patients. Nurses often identify the moment a goals-of-care conversation is needed and facilitate or initiate it.

NCLEX Pearls — Cancer Fundamentals

Benign tumors do NOT metastasize — malignant tumors can and do
CAUTION mnemonic: Change in bowel/bladder, A sore that doesn't heal, Unusual bleeding, Thickening/lump, Indigestion, Obvious change in mole, Nagging cough
Stage I = localized (best prognosis); Stage IV = distant metastasis (worst prognosis)
Initiating carcinogen causes DNA mutation; promoting agent stimulates malignant growth — both required for cancer development
Lymph node involvement (N+) worsens prognosis and affects staging
'B symptoms' in lymphoma: fever, night sweats, weight loss — indicate systemic disease
Carcinoma = epithelial origin (most common); Sarcoma = mesenchymal (connective tissue) origin
The nurse's role includes early detection advocacy, symptom management, psychosocial support, and goals-of-care facilitation
Cancer pain is undertreated — nurses advocate for adequate pain management as a quality-of-life priority

Related Resources

Standards & sources

Fact-checked Jun 21, 2026

This page is written to align with Oncology Nursing Society (ONS) · National Comprehensive Cancer Network (NCCN) · American Society of Clinical Oncology (ASCO). It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →